Cargando…
Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride
Human steroid 5α-reductase 2 (SRD5α2) as a critical integral membrane enzyme in steroid metabolism catalyzes testosterone to dihydrotestosterone. Mutations on its gene have been linked to 5α-reductase deficiency and prostate cancer. Finasteride and dutasteride as SRD5α2 inhibitors are widely used an...
Autores principales: | Xiao, Qingpin, Wang, Lei, Supekar, Shreyas, Shen, Tao, Liu, Heng, Ye, Fei, Huang, Junzhou, Fan, Hao, Wei, Zhiyi, Zhang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373137/ https://www.ncbi.nlm.nih.gov/pubmed/32702725 http://dx.doi.org/10.21203/rs.3.rs-40159/v1 |
Ejemplares similares
-
Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
por: Xiao, Qingpin, et al.
Publicado: (2020) -
The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2017) -
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
por: Kiguradze, Tina, et al.
Publicado: (2017) -
Development of finasteride polymer microspheres for systemic application in
androgenic alopecia
por: Kim, Ju Hee, et al.
Publicado: (2019) -
Methylated CpG dinucleotides in the 5-α reductase 2 gene may explain finasteride resistance in benign prostatic enlargement patients
por: Lin, Zhe-Min, et al.
Publicado: (2020)